Clorox Q4 EPS falls 50% to $1.34; organic sales drop 13% on ERP lapping

CLOROX CO /DE/

Net sales $1.95B, down 2% YoY; organic sales down 13% due to ERP transition lapping (~13.5 pts).
Gross margin 41.3%, down 520 bps; impacted by lower volume, GOJO inventory step-up, higher costs.
Diluted EPS $1.34 vs $2.68; adjusted EPS $1.66 vs $2.87, both down ~50% and 42% respectively.
Completed GOJO acquisition in April 2026; added ~10 points to net sales in Q4.
FY27 outlook: challenging environment expected; no quantitative guidance provided.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.